Brief: A1M Pharma: Mitochondrial protective effect of rA1M in preclinical studies
Jan 4 (Reuters) - A1M Pharma AB A1M.ST :
* Announces that rA1M shows mitochondrial protective effect,
according to preliminary results from preclinical studies
conducted in cooperation with NeuroVive Pharmaceutical
Source text: http://bit.ly/2iI2Qet
Further company coverage: A1M.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))